2-(5-FORMYL-2,4-DIMETHYL-1H-PYRROL-3-YL)ACETIC ACID, 97.0%, 1g

1-(4-Fluoro-phenyl)-3-phenyl-1H-pyrazole-5-carboxylic acid, 98.0%, 250mg

3,3-Bis(bromomethyl)-1-tosylazetidine, 95.0%, 250mg

Pseudouridina-5'-trifosfato, ≥95 %, 50 µl, envase de plástico.

3-Methoxy-3-methylazetidine hydrochloride, 95.0%, 10g

Filtres à membrane ester mixte de cellulose 0,2 µm, 47 mm, sans grille, non stérile, 100 pièce(s)

L-LEUCINE-15N, 95.0%, 1g

(2E)-1-(2,4-dichlorophenyl)-3-(4-methylphenyl)prop-2-en-1-one, 95.0%, 2g

1-Benzylpiperidine-4-carbonitrile, 95.0%, 25g

3-(5-Bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-6-(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 98%, 100mg

tert-Butyl (2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)carbamate, 97%, 10g

4-tert-Butyl-2-ethoxy-benzoic acid, 97.0%, 10g

3-Butyl-8-hydroxymethyl-7-propyl-3,7-dihydro-purine-2,6-dione, 250mg